New York Life Investment Management LLC Alnylam Pharmaceuticals, Inc. Transaction History
New York Life Investment Management LLC
- $9.66 Billion
- Q4 2024
A detailed history of New York Life Investment Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 2,384 shares of ALNY stock, worth $675,482. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,384
Previous 2,231
6.86%
Holding current value
$675,482
Previous $613,000
8.65%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding ALNY
# of Institutions
671Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.7 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.61 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.71 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.97 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.24 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $34.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...